Sequence analysis of myozenin 2 in 438 European patients with familial hypertrophic cardiomyopathy

Medical Science Monitor

Volumn 14, Issue 7, 2008, Pages

  Posch, Maximilian G ^a,b   Thiemann, Laura ^a,b   Tomasov, Pavol ^c   Veselka, Josef ^c   Cardim, Nuno ^d   Garcia Castro, Mónica ^e   Coto, Eliecer ^e   Perrot, Andreas ^a,b   Geier, Christian ^a,b   Dietz, Rainer ^a,b   Haverkamp, Wilhelm ^a,b   Özcelik, Cemil ^a,b,f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d HOSPITAL PULIDO VALENTE   (Portugal)

^e Central University Hospital of Asturias   (Spain)

^f Experimental and Clinical Research Center   (Germany)

Author keywords

Calsarcin; Cardiomyopathy; Myozenin

Indexed keywords

ARTICLE; COHORT ANALYSIS; EXON; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; MYOZENIN 2 GENE; PATHOGENESIS; SEQUENCE ANALYSIS;

CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MUSCLE PROTEINS; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 48349096078     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Veselka J: Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: A review of the literature. Med Sci Monit, 2007; 13(4): RA62-68
2. Elliott P, McKenna WJ: Hypertrophic cardiomyopathy. Lancet, 2004; 303: 1881-91
3. Richard P, Charron P, Carrier L et al: Hypertrophic cardiomyopathy distribution of disease genes, spectrum of mutations, and implications for a molecular diagnostic strategy. Circulation, 2003; 107; 2227-32
4. Geier C, Perrot, A, Ozcelik C et al: Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation, 2003; 107: 1390-95
5. Hayashi T, Arimura T, Itoh-Satoh M et al: Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol, 2004; 44: 2192-201
6. Hoffmann B, Schmidt-Traub H, Perrot A et al: First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy Hum Mutat, 2001; 17: 524
7. Faulkner G, Pallavicini A, Comelli A et al: FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle. J Biol Chem, 2000; 275: 41234-42
8. Frey N, Richardson JA, Olson EN: Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci USA, 2000; 97: 14632-37
9. Mohapatra B, Jimenez S, Lin JH et al: Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab, 2003; 80: 207-15
10. Vorgerd M, van der Ven PF, Bruchertseifer V et al: A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. Am J Hum Genet, 2005; 77: 297-304
11. Frey N, Barrientos T,Shelton JM et al: Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated, cardiomyopathy in response to pathological biomechanical stress. Nat Med, 2004; 12: 1336-43
12. Osio A, Tan L, Chen SN et al: Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res, 2007; 100: 766-68
13. Garcia-Castro M, Reguero JR, Batalla A et al: Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain and cardiac troponin T genes among Spanish patients. Clin Chem, 2003; 49: 1279-85
14. Garcia-Castro M, Reguero JR, Alvarez V et al: Hypertrophic Cardiomyopathy linked to homozygosity for a new mutation in the MYBPC3 gene (A627V) suggests a dosage effect. Int J Cardiol, 2005; 102: 501-7
15. Kabaeva ZT, Perrot A, Wolter B et al: Systematic analysis of the regulatory and essential myosin light chain genes: genetic variants and mutations in hypertrophic cardiomyopathy. Eur J Hum Genet, 2002; 10: 741-48
16. Perrot A, Schmidt-Traub H, Hoffmann B et al: Prevalence of cardiac beta-myosin heavy chain gene mutations in patient with hypertrophic cardiomyopathy. J Mol Med, 2005; 83: 468-77
17. Posch MG, Perrot A, Dietz R et al: Mutations in MYOZ1 as well as MYOZ2 encoding the calsarcins are not associated with idiopathic and familial dilated cardiomyopathy. Mol Genet Metab, 2007; 91: 207-8
18. Zeller R, Ivandic BT, Ehlermann P et al: Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. 2000 J Mol Med, 2006; 84: 682-91